|
Mental health
conditions have a tendency to move
upwards in ranking, while ranked as the
fourth leading cause of disease burden
in 2000, it is expected that depression
will move to second place by 2020,
second only to heart disease.34
Population surveys suggest that while
the incidence of depression is higher in
the developed countries of North America
and Europe than in other regions, it is
none the less a common condition
throughout the world.38 The
rate difference is often attributed to
underdiagnosis, but newer data suggests
that the Western diet, stressful
lifestyle and higher toxicant exposures
contribute to the prevailing high rates
in Westernized countries.32
The
monoamine theory fails to explain why
the incidences of depression are
increasing on a world wide basis and is
more prevalent in developed countries.
1
Depression Epidemiology
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
|
